BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31021442)

  • 1. The t(11;14)(q13;q32)/CCND1-IGH translocation in chronic lymphocytic leukaemia/small lymphocytic lymphoma: an unusual genetic aberration during the natural clinical course.
    Liu Y; Roshal M; Xiao W; Zhang Y; Aypar U; Yu W; Nafa K; Arcila M; Moung C; Dogan A; Park J; Ho C
    Histopathology; 2019 Aug; 75(2):291-294. PubMed ID: 31021442
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-IGH: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma.
    Zhao Y; McCracken J; Rehder C; Wang E
    Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e310-e313. PubMed ID: 34840090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acquisition of IgH/CCND1 translocation during the natural disease course in a patient with chronic lymphocytic leukemia].
    Arai K; Takagi F; Sonokawa S; Suzuki S; Ito E; Takeuchi K; Kumagai T
    Rinsho Ketsueki; 2018; 59(1):51-57. PubMed ID: 29415938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
    Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
    Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
    Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
    Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the t(11;14)(q13;q32) without CCND1/IGH fusion in a case of acute myeloid leukemia.
    Tarsitano M; Palmieri S; Ferrara F; Riccardi C; Cavaliere ML; Vicari L
    Cancer Genet Cytogenet; 2009 Dec; 195(2):164-7. PubMed ID: 19963117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The t(11;14)(q13;q32)/CCND1-IGH translocation is a recurrent secondary genetic aberration in relapsed chronic lymphocytic leukemia.
    Schliemann I; Oschlies I; Nagel I; Maria Murga Penas E; Siebert R; Sander B
    Leuk Lymphoma; 2016 Nov; 57(11):2672-6. PubMed ID: 26916968
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
    Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia with t(6;14) (p21;q32) CCND3-IGH: CCND3 rearrangement does not necessarily define a cyclin D1-negative mantle cell lymphoma.
    Zhao Y; McCracken J; Rehder C; Wang E
    Hematol Oncol; 2022 Feb; 40(1):111-114. PubMed ID: 34596253
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclin D1/PRAD1/BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocation.
    Hosokawa Y; Joh T; Maeda Y; Arnold A; Seto M
    Int J Cancer; 1999 May; 81(4):616-9. PubMed ID: 10225453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 overexpression in proliferation centres of small lymphocytic lymphoma/chronic lymphocytic leukaemia.
    Teixeira Mendes LS; Peters N; Attygalle AD; Wotherspoon A
    J Clin Pathol; 2017 Oct; 70(10):899-902. PubMed ID: 28408436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia.
    Hwang Y; Lee JY; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2011 Jun; 33(3):299-304. PubMed ID: 21272268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.
    Manda-Mapalo MT; Khalili P; Quintana D; Rabinowitz I; Zhang QY
    Cancer Genet; 2016 Oct; 209(10):481-485. PubMed ID: 27810077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.
    Gradowski JF; Sargent RL; Craig FE; Cieply K; Fuhrer K; Sherer C; Swerdlow SH
    Am J Clin Pathol; 2012 Jul; 138(1):132-9. PubMed ID: 22706868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
    Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aggressive B-cell lymphoma with IGH/MYC, IGH/BCL2, and IGH/CCND1 translocations].
    Nishijima A; Noguchi Y; Narukawa K; Takano H; Oshikawa G
    Rinsho Ketsueki; 2019; 60(10):1425-1430. PubMed ID: 31695002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.
    Sathanoori M; Shekhter-Levin S; Marks SM; Swerdlow SH
    Cancer Genet Cytogenet; 2007 Jan; 172(2):158-64. PubMed ID: 17213026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional and post-transcriptional mechanisms induce cyclin-D1 over-expression in B-chronic lymphoproliferative disorders.
    Sola B; Salaün V; Ballet JJ; Troussard X
    Int J Cancer; 1999 Oct; 83(2):230-4. PubMed ID: 10471532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation.
    Komatsu H; Yoshida K; Seto M; Iida S; Aikawa T; Ueda R; Mikuni C
    Br J Haematol; 1993 Oct; 85(2):427-9. PubMed ID: 8280621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.